Published online Mar 27, 2026. doi: 10.4240/wjgs.v18.i3.115484
Revised: December 24, 2025
Accepted: January 20, 2026
Published online: March 27, 2026
Processing time: 155 Days and 10.9 Hours
The standard natural orifice specimen extraction surgery (NOSES) type IV pro
To retrospectively compare postoperative outcomes of standard NOSES and mo
A retrospective analysis was performed on 40 patients who underwent NOSES type IV surgery for rectosigmoid cancer at Shenzhen People’s Hospital between July 2021 and October 2025. The patients were divided into two groups: 19 treated with the modified NOSES procedure (modified group) and 21 treated with the standard NOSES procedure (control group). The baseline characteristics, peri
The modified group experienced less intraoperative blood loss, shorter operative time, and lower operative cost compared with the control group (all P < 0.05), and achieved earlier first defecation. One Grade B anastomotic leak occurred in the control group. Baseline characteristics, lymph node yield, postoperative pain, inflammatory markers, complication rates, and other recovery outcomes did not differ significantly between groups (all P > 0.05). In multivariable analysis, the modified procedure was independently associated with reduced operative cost (β = -1307, P < 0.001) and operative time (β = -49.9 minutes, P = 0.019). Larger tumor size and greater distance from the anus were associated with higher operative cost.
The modified NOSES technique may reduce operative trauma, shorten procedure time, lower perioperative resource use and accelerate postoperative recovery, with similar outcomes to the standard approach. These results require confirmation in larger, prospective multicenter studies.
Core Tip: This study compared the conventional and modified natural orifice specimen extraction surgery (NOSES) type IV procedures for rectosigmoid cancer. Compared to the conventional technique, the modified technique had simplified operative steps and eliminated the need for a circular stapler, thereby reducing operative time, blood loss, and surgical costs without compromising oncological safety. Postoperative recovery, including bowel function and complication rates, was comparable between groups. These findings suggest that the modified NOSES IV approach is a safe, efficient, and cost-effective alternative for minimally invasive radical resection of rectosigmoid cancer.
